Chiesi Farmaceutici inaugurates the Chiesi Foundation on the occasion of its 70th Anniversary
Alberto Chiesi, President and CEO, Paolo Chiesi, Vice-President and Research and Development Director, Professor Dario Olivieri, Director of the Department of Clinical Sciences, Section of Respiratory Diseases, University of Parma, and Alessandro Fulgheri,Head of External Communications at Chiesi, presented the Foundation during a press conference held in Parma.
"Seventy years of presence and continued growth in the pharmaceutical industry, clearly demonstrates Chiesi's deep-rooted and strong strategic foundation - stated Alberto Chiesi - based on two key concepts: innovation and internationalization". In fact, Research and Development can be considered the main driver of Chiesi's strategy, which has at its core tools for innovation. "We invest between 13 and 14% of our income in research - said Paolo Chiesi - an investment percentage comparable to the leading European Companies and a benchmark for the Italian pharmaceutical industry".
"The idea of a Foundation - continued Paolo Chiesi - arose from the desire to contribute to the dissemination of scientific know-how in research areas of particular interest and social impact for our Group (neonatology, pneumology, cardiology), well beyond the ordinary commercial interests of a company".
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.